Literature DB >> 17079472

Ras induces chromosome instability and abrogation of the DNA damage response.

Adili Abulaiti1, Aphrothiti J Fikaris, Oxana M Tsygankova, Judy L Meinkoth.   

Abstract

Ras mutations are frequent in thyroid tumors, the most common endocrine malignancy. The ability of Ras to transform thyroid cells is thought to rely on its mitogenic activity. Unexpectedly, acute expression of activated Ras in normal rat thyroid cells induced a DNA damage response, followed by apoptosis. Notably, a subpopulation of cells evaded apoptosis and emerged with features of transformation, including the loss of epithelial morphology, dedifferentiation, and the acquisition of hormone- and anchorage-independent proliferation. Strikingly, the surviving cells showed marked chromosomal instability. Acutely, Ras stimulated replication stress as evidenced by the induction of ataxia telangiectasia mutated and Rad3-related protein kinase (ATR) activity (Chk1 phosphorylation) and of gammaH2A.X, a marker of DNA damage. Despite the activation of a checkpoint, cells continued through mitosis in the face of DNA damage, resulting in an increase in cells harboring micronuclei, an indication of defects in chromosome segregation and other forms of chromosome damage. Cells that survived exposure to Ras continued to exhibit replication stress (ATR activation) but no longer exhibited gammaH2A.X or full activation of p53. When rechallenged with Ras or DNA-damaging agents, the surviving cells were more resistant to apoptosis than parental cells. These data show that acute expression of activated Ras is sufficient to induce chromosomal instability in the absence of other signals, and suggest that Ras-induced chromosomal instability arises as a consequence of defects in the processing of DNA damage. Hence, abrogation of the DNA damage response may constitute a novel mechanism for Ras transformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079472     DOI: 10.1158/0008-5472.CAN-06-2351

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Oncogenes create a unique landscape of fragile sites.

Authors:  Karin Miron; Tamar Golan-Lev; Raz Dvir; Eyal Ben-David; Batsheva Kerem
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

2.  Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.

Authors:  G Y Wang; C N Wood; J A Dolorito; E Libove; E H Epstein
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

Review 3.  Senescence and life span.

Authors:  Peter J Hornsby
Journal:  Pflugers Arch       Date:  2009-09-08       Impact factor: 3.657

4.  Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR.

Authors:  David W Schoppy; Ryan L Ragland; Oren Gilad; Nishita Shastri; Ashley A Peters; Matilde Murga; Oscar Fernandez-Capetillo; J Alan Diehl; Eric J Brown
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 5.  K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Authors:  Nikolaos Margetis; Myrsini Kouloukoussa; Kyriaki Pavlou; Spyridon Vrakas; Theodoros Mariolis-Sapsakos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 6.  Cellular aging and cancer.

Authors:  Peter J Hornsby
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-11       Impact factor: 6.312

7.  RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

Authors:  Gong Yang; Imelda Mercado-Uribe; Asha S Multani; Subrata Sen; Ie-Ming Shih; Kwong-Kwok Wong; David M Gershenson; Jinsong Liu
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

8.  Downregulation of Rap1GAP contributes to Ras transformation.

Authors:  Oxana M Tsygankova; Gregory V Prendergast; Kanchan Puttaswamy; Yan Wang; Michael D Feldman; Hongbin Wang; Marcia S Brose; Judy L Meinkoth
Journal:  Mol Cell Biol       Date:  2007-07-23       Impact factor: 4.272

9.  Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation.

Authors:  Y Aylon; N Yabuta; H Besserglick; Y Buganim; V Rotter; H Nojima; M Oren
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

10.  Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy.

Authors:  Mona Meyer; Daniela Rübsamen; Robert Slany; Thomas Illmer; Kathleen Stabla; Petra Roth; Thorsten Stiewe; Martin Eilers; Andreas Neubauer
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.